Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions, and additional information
But the GLP-1 market is getting crowded, and oral alternatives and multiple new injectables are in the pipeline, which could push pricing toward the lower end of that range
I think the gallbladder issue is the most underappreciated risk in the entire Retatrutide conversation
And this year, two phase three studies were presented
Food thoughts decrease, and emotional eating often becomes easier to manage
Clinical studies and our extensive patient experience at Internal Medicine and Family Practice show that the vast majority of patients experience a substantial decrease in hunger and achieve meaningful weight loss